Clinical Trial

Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F

Study acronym: RUSH1F
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The overall goal of this project, co-funded by the Foundation Fighting Blindness and the USHER 1F Collaborative is to characterize the natural history of disease progression in patients with PCDH15 mutations in order to accelerate the development of outcome measures for clinical trials.
Protocol Amendment History 21 amendments
This ClinicalTrials.gov record has been amended 21 times since 2021-02-19; most recent amendment 2026-02-02.
Status change: Recruiting → Active, Not Recruiting 2023-07-17
Status change: Not Yet Recruiting → Recruiting 2021-05-25
Trial Details
NCT Number NCT04765345
Lead Sponsor Jaeb Center for Health Research
Collaborators: Usher 1F Collaborative, Marjorie C. Adams Foundation, Foundation Fighting Blindness
Conditions Retinal Degeneration, Retinitis Pigmentosa, Eye Diseases, Hereditary
Enrollment 44 participants
Start Date 2021-06-08
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-04